Australia's Clarity Pharmaceuticals soars on new cancer treatment
18/12/2024 04:39
** Clarity Pharmaceuticals CU6.AX soars as much as 19.3%
to A$5.5; highest intraday pct gain
** Stock hits highest since Dec. 10
** Co develops new radio-pharmaceutical to diagnose and
treat cancer
** Says new product shows strong tumour targeting in
pre-clinical models
** Nearly 3 mln shares traded vs the 30-day avg of ~1.4 mln
** Stock up 173% YTD
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial